KELLY SMILEY: Open Payments
NPI 1356647655 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$415 in 18 payments from 6 companies in 2025. Trend: 2023 $230 · 2024 $292 · 2025 $415
Food & beverage: $415
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $108 |
| Indivior Inc. | 5 | $90 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| ABBVIE INC. | 2 | $55 |
| Braeburn Inc. | 2 | $49 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
Products named: SUBLOCADE, REXULTI, ARISTADA, VIVITROL, BRIXADI, COBENFY, MAVYRET, VRAYLAR.
Industry payments across CO — which companies pay providers there.
